dCMP

We are dCMP CAS:1032-65-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:dCMP
CAS.NO:1032-65-1
Synonyms:Deoxycytidylic Acid Hydrate; 2'-Deoxycytidylic acid
2'-Deoxycytidine-5'-monophosphoric acid
2-Deoxycytidine-5'-monophosphoric acid
2'-Deoxycytidine 5'-monophosphate
Molecular Formula:C9H14N3O7P
Molecular Weight:307.19700
 
Physical and Chemical Properties:
Density:2.01
Melting point:169-172ºC
Boiling point:633.8ºC
Flash point:337.1ºC
 
Specification:
Appearance:White to off-white solid
Assay(HPLC):≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:A phosphorylated metabolite of the deoxyribonucleoside 2’-Deoxycytidine. A constituent of Deoxyribonucleic acid. Studies show that it increases influenza virus antigen-induced immune cell proliferation.

dCMP


Related News: On the other hand, the company has many new products in recent years, including Duqiao Base, Yancheng United Chemical and Dezhou United Chemical. These new products are mostly customized products with strong profitability, which has improved the gross profit margin of the industrial business.1,2,4-trifluorobenceno CAS:367-23-7 On the other hand, the company has many new products in recent years, including Duqiao Base, Yancheng United Chemical and Dezhou United Chemical. These new products are mostly customized products with strong profitability, which has improved the gross profit margin of the industrial business.897921-59-4 ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.381-98-6 ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.

Related Products
Product Name
2-Bromophenylboronicacid View Details
N-phenacylacetamide View Details
2-Chloro-5-fluoro-3-methylpyridine View Details
5-(3-Fluorophenyl)-2-methylpyridine manufacturer 2-Chloroacrylonitrile manufacturer 2,3,4,5-Tetrahydro-5-methyl-1H-pyrido[4,3-b]indol-1-one manufacturer 1-(4-Iodophenyl)piperidin-2-one manufacturer 2-Acetyl-6-methoxynaphthalene manufacturer